Microsatellite instability testing by immunohistochemistry: Initial evaluation of hereditary nonpolyposis colon cancer and potential prognostic and therapeutic information

Journal of Histotechnology

Volumn 27, Issue 3, 2004, Pages 169-172

  Tripp, Sheryl R ^a   Gedge, Friederike E H ^a   Lyon, Elaine ^a   Samowitz, Wade S ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Hereditary nonpolyposis colon cancer (HNPCC); Immunohistochemistry (IHC); Microsatellite instability (MSI); Mismatch repair genes (hMLH1 hMSH2 hMSHO); Polymerase chain reaction (PCR)

Indexed keywords

MICROSATELLITE DNA; PROTEIN MLH1; PROTEIN MSH2; TUMOR MARKER;

ACCURACY; ARTICLE; CANCER THERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 4644237879     PISSN: 01478885     EISSN: None     Source Type: Journal    
DOI: 10.1179/his.2004.27.3.169     Document Type: Article

References (9)

1. Aaltonen LA, Peltomäki P, Mecklin JP, Järvinen H, Jass JR, Green JS, Lynch HT, Watson P, Tallqvist G, Juhola M, Sistonen P, Hamilton SR, Kenneth WK, Vogelstein B, de la Chapelle A: Replication errors in benign and malignant tumors for hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645-1648, 1994
2. Rigau V, Sebbagh N, Olschwang S, Paraf F, Mourra N, Parc Y, Flejou J-F: Microsatellite instability in colorectal carcinoma. Arch Pathol Lab Med 127:694-700, 2003
3. Berends MJW, Wu Y, Sijmons RH, Mensink RGJ, van der Sluis T, Hordijk-Hos JM, de Vries EGE, Hollema H, Karrenbeld A, Buys CHCM, van der Zee AGJ, Hofstra RMW, Kleibeuker JH: Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70:26-37, 2002
4. Pare YR, Hailing KC, Wang L, Christensen ER, Cunningham JM, French AJ, Burgart LJ, Price-Troska TL, Roche PC, Thibodeau SN: hMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res 60:2225-2231, 2000
5. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LKF, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M: Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 23:1248-1260, 1999
6. Samowitz WS, Curtin K, Ma K-N, Schaffer D, Coleman LW, Leppert M, Slattery ML: Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10:917-923, 2001
7. Gryfe R, Kim H, Hsieh ETK, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342:69-77, 2000
8. Ribic CM, Sargent DJ, Morre MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247-257, 2003
9. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani N, Srivastava S: A national cancer institute work-shop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998